XSHG
688029
Jul 10, Last price
73.12
1D
-0.67%
1Q
-8.61%
IPO
-17.08%
Name
Micro-Tech Nanjing Co Ltd
Chart & Performance
P/E
—
P/S
—
EPS
3.06
Div Yield, %
2.04%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
19.01%
Revenues
3.17b
+14.94%
Net income
570m
+3.05%
CFO
688m
+12.22%
Dividend
Sep 26, 20250.5 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Micro-Tech (Nanjing) Co., Ltd. is a key manufacturer and global supplier of non-vascular stents and disposable biopsy forceps. The company's primary markets span China, Europe, North America, and Oceania. Its extensive product portfolio includes specialized gastroenterology devices such as longwire and shortwire biliary stents, biopsy instruments, dilation and hemostasis products, EUS tools, nitinol stents, resection devices, retrieval systems, and related accessories. For pulmonology, offerings comprise airway stents, biopsy tools, dilation balloons, cytology brushes, retrieval devices, and additional accessories. Beyond its own product lines, Micro-Tech also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services to other medical device firms. Founded in 1999, the company is headquartered in Nanjing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||